Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to L. Celio et al.
Minatogawa H, Izawa N, Nakajima TE. Minatogawa H, et al. Br J Cancer. 2024 May 15. doi: 10.1038/s41416-024-02708-5. Online ahead of print. Br J Cancer. 2024. PMID: 38750116 No abstract available.
Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.
Uchinami Y, Yasuda K, Minatogawa H, Dekura Y, Nishikawa N, Kinoshita R, Nishioka K, Katoh N, Mori T, Otsuka M, Miyamoto N, Suzuki R, Kobashi K, Shimizu Y, Taguchi J, Tsushima N, Kano S, Homma A, Aoyama H. Uchinami Y, et al. Among authors: minatogawa h. Radiat Oncol J. 2024 Mar;42(1):74-82. doi: 10.3857/roj.2023.00374. Epub 2024 Mar 18. Radiat Oncol J. 2024. PMID: 38549386 Free PMC article.
Dexamethasone-sparing on days 2-4 with combined palonosetron, neurokinin-1 receptor antagonist, and olanzapine in cisplatin: a randomized phase III trial (SPARED Trial).
Minatogawa H, Izawa N, Shimomura K, Arioka H, Iihara H, Sugawara M, Morita H, Mochizuki A, Nawata S, Mishima K, Tsuboya A, Miyaji T, Honda K, Yokomizo A, Hashimoto N, Yanagihara T, Endo J, Kawaguchi T, Furuya N, Sone Y, Inada Y, Ohno Y, Katada C, Hida N, Akiyama K, Ichikura D, Konomatsu A, Ogura T, Yamaguchi T, Nakajima TE. Minatogawa H, et al. Br J Cancer. 2024 Feb;130(2):224-232. doi: 10.1038/s41416-023-02493-7. Epub 2023 Nov 16. Br J Cancer. 2024. PMID: 37973958 Clinical Trial.
Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective study.
Dekura Y, Yasuda K, Minatogawa H, Uchinami Y, Tsushima N, Suzuki T, Kano S, Mori T, Nishioka K, Kobashi K, Katoh N, Homma A, Aoyama H. Dekura Y, et al. Among authors: minatogawa h. J Radiat Res. 2024 Jan 19;65(1):63-70. doi: 10.1093/jrr/rrad080. J Radiat Res. 2024. PMID: 37952082 Free PMC article.
Brain metastases in Japanese NSCLC patients: prognostic assessment and the use of osimertinib and immune checkpoint inhibitors-retrospective study.
Higaki H, Nishioka K, Otsuka M, Nishikawa N, Shido M, Minatogawa H, Nishikawa Y, Takashina R, Hashimoto T, Katoh N, Taguchi H, Kinoshita R, Yasuda K, Mori T, Uchinami Y, Koizumi F, Fujita Y, Takahashi S, Hattori T, Nishiyama N, Aoyama H. Higaki H, et al. Among authors: minatogawa h. Radiat Oncol. 2023 Feb 7;18(1):25. doi: 10.1186/s13014-023-02218-3. Radiat Oncol. 2023. PMID: 36750899 Free PMC article.
Detailed analysis of failure patterns using deformable image registration in hypopharyngeal cancer patients treated with sequential boost intensity-modulated radiotherapy.
Otsuka M, Yasuda K, Uchinami Y, Tsushima N, Suzuki T, Kano S, Suzuki R, Miyamoto N, Minatogawa H, Dekura Y, Mori T, Nishioka K, Taguchi J, Shimizu Y, Katoh N, Homma A, Aoyama H. Otsuka M, et al. Among authors: minatogawa h. J Med Imaging Radiat Oncol. 2023 Feb;67(1):98-110. doi: 10.1111/1754-9485.13491. Epub 2022 Nov 14. J Med Imaging Radiat Oncol. 2023. PMID: 36373823 Free article.
Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy.
Kano S, Tsushima N, Suzuki T, Hamada S, Yokokawa T, Idogawa H, Yasuda K, Minatogawa H, Dekura Y, Aoyama H, Homma A. Kano S, et al. Among authors: minatogawa h. Int J Clin Oncol. 2021 Jul;26(7):1179-1187. doi: 10.1007/s10147-021-01889-w. Epub 2021 Jun 4. Int J Clin Oncol. 2021. PMID: 34086112 Free article.
Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and Cyclophosphamide.
Suehiro M, Kojima Y, Takahashi M, Ito Y, Keira T, Ikegawa K, Minatogawa H, Tsugawa K, Tanaka T. Suehiro M, et al. Among authors: minatogawa h. Cancer Manag Res. 2021 Feb 17;13:1617-1624. doi: 10.2147/CMAR.S280995. eCollection 2021. Cancer Manag Res. 2021. PMID: 33628052 Free PMC article.
Analysis of acute-phase toxicities of intensity-modulated proton therapy using a model-based approach in pharyngeal cancer patients.
Yasuda K, Minatogawa H, Dekura Y, Takao S, Tamura M, Tsushima N, Suzuki T, Kano S, Mizumachi T, Mori T, Nishioka K, Shido M, Katoh N, Taguchi H, Fujima N, Onimaru R, Yokota I, Kobashi K, Shimizu S, Homma A, Shirato H, Aoyama H. Yasuda K, et al. Among authors: minatogawa h. J Radiat Res. 2021 Mar 10;62(2):329-337. doi: 10.1093/jrr/rraa130. J Radiat Res. 2021. PMID: 33372202 Free PMC article.
14 results